A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model

Haemostasis
F S MarklandR Sposto

Abstract

OVCAR-5 is a human epithelial carcinoma cell line of the ovary, established from the ascitic fluid of a patient with progressive ovarian adenocarcinoma without prior cytotoxic treatment. The unique growth pattern of ovarian carcinoma makes it an ideal model for examining the anticancer activity of contortrostatin (CN), a homodimeric disintegrin from southern copperhead venom. FACS analysis revealed that OVCAR-5 is integrin alphavbeta3 negative, but alphavbeta5 positive. CN effectively blocks the adhesion of OVCAR-5 cells to several extracellular matrix proteins and inhibits tumor cell invasion through an artificial basement membrane. In a xenograft nude mouse model with intraperitoneal introduction of OVCAR-5 cells, intraperitoneal injection of CN was used for therapy. Tumor dissemination in CN-treated versus control groups was studied by gross examination, and antiangiogenic potential was examined by factor VIII immunohistochemistry and image analysis. CN not only significantly inhibited ovarian cancer dissemination in the nude mouse model, but it also dramatically prevented the recruitment of blood vessels to tumors at secondary sites.

Citations

Dec 15, 2012·Apoptosis : an International Journal on Programmed Cell Death·Gamal BadrDouaa Sayed
Jul 3, 2013·The International Journal of Biochemistry & Cell Biology·Cezary Marcinkiewicz
Aug 9, 2003·Toxicon : Official Journal of the International Society on Toxinology·Gamal Abu-SinnaTiaseer M Ibrahim
May 23, 2012·Molecular BioSystems·Adrian GuthalsNuno Bandeira
Jul 17, 2007·DNA and Cell Biology·Li GaoBaoen Shan
Nov 10, 2011·Toxins·Heloisa S Selistre-de-AraujoAna Carolina B M Martin
Apr 1, 2014·BioMed Research International·Leonardo A CalderonAndreimar M Soares
Mar 31, 2011·Toxicon : Official Journal of the International Society on Toxinology·Cho Yeow Koh, R Manjunatha Kini
Mar 31, 2009·Toxicon : Official Journal of the International Society on Toxinology·Mohamed F El-RefaeiNurul H Sarkar
Mar 20, 2009·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Heiki VijaJüri Siigur
Feb 24, 2007·Toxicon : Official Journal of the International Society on Toxinology·Jing TianMary Ann McLane
Aug 23, 2006·Journal of Cellular Biochemistry·Aixia RenYaozhou Zhang
Dec 19, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Deepika Jain, Sudhir Kumar
Nov 14, 2012·Toxicon : Official Journal of the International Society on Toxinology·Stefan HaileyMary Ann McLane
Feb 20, 2015·Cellular and Molecular Life Sciences : CMLS·T A ReeksP F Alewood
Apr 21, 2007·Molecular & Cellular Proteomics : MCP·Nuno BandeiraPavel A Pevzner
Nov 20, 2014·BMC Complementary and Alternative Medicine·Durvanei Augusto MariaItamar Romano Garcia Ruiz
Aug 3, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Mohamed K Al-SadoonGamal Badr
Mar 23, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marius Alexandru MogaLiana Pleş
Mar 18, 2021·European Journal of Pharmacology·Bushra AkhtarMuhammad Irfan Anwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.